Qiagen Seeks FDA Approval

Qiagen Seeks FDA Approval – Analyst Blog

By: Stock Market News & Stocks to Watch from StraightStocks

Posted on January 18, 2013 at 17:00 PM EST

Qiagen recently made a regulatory submission of its therascreen EGFR RGQ PCR Kit test to the U.S. Food and Drug Administration (FDA) as a proposed companion diagnostic to guide treatment with afatinib.

Related Stocks:

Laboratory Corp. of America Holdings Qiagen NV Quest Diagnostics, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates